Chirurgie bei neuroendokrinen Neoplasien des Pankreas: State of the Art

Assi HA, Mukherjee S, Kunz PL et al (2020) Surgery versus surveillance for well-differentiated, nonfunctional pancreatic neuroendocrine tumors: an 11-year analysis of the national cancer database. The Oncol 25:e276–e283

Bartsch DK, Waldmann J, Fendrich V et al (2012) Impact of lymphadenectomy on survival after surgery for sporadic gastrinoma. Br J Surg 99:1234–1240

Bartsch DK, Albers M, Knoop R et al (2013) Enucleation and limited pancreatic resection provide long-term cure for insulinoma in multiple endocrine neoplasia type 1. Neuroendocrinology 98:290–298

Beane JD, Borrebach JD, Billderback A et al (2021) Small pancreatic neuroendocrine tumors: resect or enucleate? Am J Surg 222:29–34

Beger HG, Siech M, Poch B et al (2015) Limited surgery for benign tumours of the pancreas: a systematic review. World J Surg 39:1557–1566

Bilimoria KY, Talamonti MS, Tomlinson JS et al (2008) Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg 247:490–500

Björnsson B, Larsson AL, Hjalmarsson C et al (2020) Comparison of the duration of hospital stay after laparoscopic or open distal pancreatectomy: randomized controlled trial. Br J Surg 107:1281–1288

Caplin ME, Pavel M, Ćwikła JB et al (2014) Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med 371:224–233

Chivukula SV, Tierney JF, Hertl M et al (2020) Operative resection in early stage pancreatic neuroendocrine tumors in the United States: are we over- or undertreating patients? Surgery 167:180–186

Conrad C, Kutlu OC, Dasari A et al (2016) Prognostic value of lymph node status and extent of lymphadenectomy in pancreatic neuroendocrine tumors confined to and extending beyond the pancreas. J Gastrointest Surg 20:1966–1974

Crippa S, Zerbi A, Boninsegna L et al (2012) Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections. Arch Surg 147:261–266

Curran T, Pockaj BA, Gray RJ et al (2015) Importance of lymph node involvement in pancreatic neuroendocrine tumors: impact on survival and implications for surgical resection. J Gastrointest Surg 19:152–160 (discussion 160)

de Rooij T, van Hilst J, van Santvoort H et al (2019) Minimally invasive versus open distal pancreatectomy (LEOPARD): a multicenter patient-blinded randomized controlled trial. Ann Surg 269:2–9

Dedieu A, Rault A, Collet D et al (2011) Laparoscopic enucleation of pancreatic neoplasm. Surg Endosc 25:572–576

Delle Fave G, Kwekkeboom DJ, Van Cutsem E et al (2012) ENETS consensus guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology 95:74–87

Delle Fave G, O’toole D, Sundin A et al (2016) ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms. Neuroendocrinology 103:119–124

Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS), Netzwerk Neuroendokrine Tumoren (NeT) e.V. (Patientenvertretung), Bundesorganisation Selbsthilfe NeuroEndokrine Tumoren e.V. (NET-sgh) (Patientenvertretung) et al (2018) Practice guideline neuroendocrine tumors—AWMF-Reg. 021–27. Z Gastroenterol 56:583–681

Drymousis P, Raptis DA, Spalding D et al (2014) Laparoscopic versus open pancreas resection for pancreatic neuroendocrine tumours: a systematic review and meta-analysis. HPB (Oxford) 16:397–406

Ei S, Mihaljevic AL, Kulu Y et al (2021) Enucleation for benign or borderline tumors of the pancreas: comparing open and minimally invasive surgery. HPB (Oxford) 23:921–926

Falconi M, Eriksson B, Kaltsas G et al (2016) ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology 103:153–171

Fendrich V, Bartsch DK (2017) Surgical therapy of sporadic pancreatic neuroendocrine neoplasias G1/G2. Visc Med 33:344–350

Fendrich V, Langer P, Waldmann J et al (2007) Management of sporadic and multiple endocrine neoplasia type 1 gastrinomas. Br J Surg 94:1331–1341

Finkelstein P, Sharma R, Picado O et al (2017) Pancreatic neuroendocrine tumors (panNETs): analysis of overall survival of nonsurgical management versus surgical resection. J Gastrointest Surg 21:855–866

Fischer L, Bergmann F, Schimmack S et al (2014) Outcome of surgery for pancreatic neuroendocrine neoplasms. Br J Surg 101:1405–1412

Fottner C, Ferrata M, Weber MM (2017) Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): when to consider, how to diagnose? Rev Endocr Metab Disord 18:393–410

Gaujoux S, Partelli S, Maire F et al (2013) Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. J Clin Endocrinol Metab 98:4784–4789

Gratian L, Pura J, Dinan M et al (2014) Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States. Ann Surg Oncol 21:3515–3521

Guerrini GP, Lauretta A, Belluco C et al (2017) Robotic versus laparoscopic distal pancreatectomy: an up-to-date meta-analysis. BMC Surg 17:105

Hackert T, Hinz U, Fritz S et al (2011) Enucleation in pancreatic surgery: indications, technique, and outcome compared to standard pancreatic resections. Langenbecks Arch Surg 396:1197–1203

Hackert T, Probst P, Knebel P et al (2018) Pylorus resection does not reduce delayed gastric emptying after partial pancreatoduodenectomy: a blinded randomized controlled trial (PROPP study, DRKS00004191). Ann Surg 267:1021–1027

Hashim YM, Trinkaus KM, Linehan DC et al (2014) Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg 259:197–203

Heidsma CM, van Roessel S, van Dieren S et al (2021) International validation of a nomogram to predict recurrence after resection of grade 1 and 2 nonfunctioning pancreatic neuroendocrine tumors. Neuroendocrinology. https://doi.org/10.1159/000518757

Hill JS, Mcphee JT, Mcdade TP et al (2009) Pancreatic neuroendocrine tumors: the impact of surgical resection on survival. Cancer 115:741–751

Howe JR, Cardona K, Fraker DL et al (2017) The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the north American neuroendocrine tumor society. Pancreas 46:715–731

Howe JR, Merchant NB, Conrad C et al (2020) The north American neuroendocrine tumor society consensus paper on the surgical management of pancreatic neuroendocrine tumors. Pancreas 49:1–33

Huttner FJ, Koessler-Ebs J, Hackert T et al (2015) Meta-analysis of surgical outcome after enucleation versus standard resection for pancreatic neoplasms. Br J Surg 102:1026–1036

Jutric Z, Grendar J, Hoen HM et al (2017) Regional metastatic behavior of nonfunctional pancreatic neuroendocrine tumors: impact of lymph node positivity on survival. Pancreas 46:898–903

Keutgen XM, Nilubol N, Glanville J et al (2016) Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors. Surgery 159:311–318

Klaiber U, Probst P, Huttner FJ et al (2020) Randomized trial of pylorus-preserving vs. pylorus-resecting pancreatoduodenectomy: long-term morbidity and quality of life. J Gastrointest Surg 24:341–352

Klotz R, Dorr-Harim C, Bruckner T et al (2021) Evaluation of robotic versus open partial pancreatoduodenectomy-study protocol for a randomised controlled pilot trial (EUROPA, DRKS00020407). Trials 22:40

Krampitz GW, Norton JA, Poultsides GA et al (2012) Lymph nodes and survival in pancreatic neuroendocrine tumors. Arch Surg 147:820–827

Kuo EJ, Salem RR (2013) Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size. Ann Surg Oncol 20:2815–2821

Lopez CL, Falconi M, Waldmann J et al (2013) Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1. Ann Surg 257:308–314

Mack CE, Schimmack S, Hackert T (2021) Sporadische nicht-funktionelle pankreatische neuroendokrine Neoplasien. In: Kreis M, Bartsch DK, Lang H (Hrsg) Viszeral- und Allgemeinchirurgie. Springer, Berlin, Heidelberg, S 1–14

Mehrabi A, Fischer L, Hafezi M et al (2014) A systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas 43:675–686

Mehrabi A, Hafezi M, Arvin J et al (2015) A systematic review and meta-analysis of laparoscopic versus open distal pancreatectomy for benign and malignant lesions of the pancreas: it’s time to randomize. Surgery 157:45–55

Modlin IM, Oberg K, Chung DC et al (2008) Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 9:61–72

Niederle B, Selberherr A, Bartsch DK et al (2021) Multiple endocrine neoplasia type 1 and the pancreas: diagnosis and treatment of functioning and non-functioning pancreatic and duodenal neuroendocrine neoplasia within the MEN1 syndrome—an international consensus statement. Neuroendocrinology 111:609–630

Niessen A, Hackert T (2022) State-of-the-art surgery for pancreatic cancer. Langenbecks Arch Surg 407(2):443–450. https://doi.org/10.1007/s00423-021-02362-y

Nießen A, Schimmack S, Sandini M et al (2021) C‑reactive protein independently predicts survival in pancreatic neuroendocrine neoplasms. Sci Rep 11:23768

Norton JA, Fraker DL, Alexander HR et al (2006) Surgery increases survival in patients with gastrinoma. Ann Surg 244:410–419

Partelli S, Bartsch DK, Capdevila J et al (2017) ENETS consensus guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinology 105:255–265

Partelli S, Gaujoux S, Boninsegna L et al (2013) Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). JAMA Surg 148:932–939

Sandini M, Strobel O, Hank T et al (2020) Pre-operative dysglycemia is associated with decreased survival in patients with pancreatic neuroendocrine neoplasms. Surgery 167:575–580

Schimmack S, Svejda B, Lawrence B et al (2011) The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors. Langenbecks Arch Surg 396:273–298

Solorzano CC, Lee JE, Pisters PW et al (2001) Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery 130:1078–1085

Strobel O, Cherrez A, Hinz U et al (2015) Risk of pancreatic fistula after enucleation of pancreatic tumours. Br J Surg 102:1258–1266

Strosberg J, Kvols L (2010) Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors. World J Gastroenterol 16:2963–2970

Tanaka M, Heckler M, Mihaljevic AL et al (2021) Systematic review and metaanalysis of lymph node metastases of resected pancreatic neuroendocrine tumors. Ann Surg Oncol 28:1614–1624

Tierney JF, Chivukula SV, Wang X et al (2019) Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery 165:644–651

Fendrich V, Langer P, Waldmann J et al (2007) Management of sporadic and multiple endocrine neoplasia type 1 gastrinomas. Br J Surg 94:1331–1341

Xiao W, Zhu J, Peng L et al (2018) The role of central pancreatectomy in pancreatic surgery: a systematic review and meta-analysis. HPB (Oxford) 20:896–904

Yao JC, Shah MH, Ito T et al (2011) Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 364:514–523

Zhang Z, Liu M, Ji S et al (2020) Prognostic value and clinical predictors of lymph node metastases in pancreatic neuroendocrine tumors. Pancreas 49:381–386

Zhao YP, Zhan HX, Zhang TP et al (2011) Surgical management of patients with insulinomas: result of 292 cases in a single institution. J Surg Oncol 103:169–174